Published in Genomics on September 01, 1993
Identification of candidate coding region single nucleotide polymorphisms in 165 human genes using assembled expressed sequence tags. Genome Res (1999) 1.70
Inactive conformation of the serpin alpha(1)-antichymotrypsin indicates two-stage insertion of the reactive loop: implications for inhibitory function and conformational disease. Proc Natl Acad Sci U S A (2000) 1.54
Progress in chronic obstructive pulmonary disease genetics. Proc Am Thorac Soc (2006) 1.51
The genetics of chronic obstructive pulmonary disease. Respir Res (2001) 1.33
Age-related differences in plasma proteins: how plasma proteins change from neonates to adults. PLoS One (2011) 1.22
Alpha1-antitrypsin deficiency. 4: Molecular pathophysiology. Thorax (2004) 1.18
Genetics and respiratory disease. 2. Alpha 1-antitrypsin deficiency, cirrhosis and emphysema. Thorax (1998) 1.17
Genetics and pulmonary medicine. 9. Molecular genetics of chronic obstructive pulmonary disease. Thorax (1999) 1.10
IL10 polymorphisms are associated with airflow obstruction in severe alpha1-antitrypsin deficiency. Am J Respir Cell Mol Biol (2007) 1.08
Updates on the COPD gene list. Int J Chron Obstruct Pulmon Dis (2012) 1.08
Hepatic fibrosis and carcinogenesis in α1-antitrypsin deficiency: a prototype for chronic tissue damage in gain-of-function disorders. Cold Spring Harb Perspect Biol (2011) 1.07
Polymorphism of SERPINE2 gene is associated with pulmonary emphysema in consecutive autopsy cases. BMC Med Genet (2010) 0.96
The genetics of chronic obstructive pulmonary disease. Respir Res (2006) 0.95
Analysis of the proteome of human airway epithelial secretions. Proteome Sci (2011) 0.94
National Emphysema Treatment Trial state of the art: genetics of emphysema. Proc Am Thorac Soc (2008) 0.92
Disease modifying genes in cystic fibrosis: therapeutic option or one-way road? Naunyn Schmiedebergs Arch Pharmacol (2006) 0.87
Plasma levels of alpha1-antichymotrypsin and secretory leukocyte proteinase inhibitor in healthy and chronic obstructive pulmonary disease (COPD) subjects with and without severe alpha1-antitrypsin deficiency. BMC Pulm Med (2007) 0.84
A Pulmonary Perspective on GASPIDs: Granule-Associated Serine Peptidases of Immune Defense. Curr Respir Med Rev (2006) 0.83
Genetics of chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis (2007) 0.82
Environmental and genetic risk factors and gene-environment interactions in the pathogenesis of chronic obstructive lung disease. Environ Health Perspect (2000) 0.81
Protein accumulation in the endoplasmic reticulum as a non-equilibrium phase transition. Nat Commun (2014) 0.78
Association of alpha(1)-antichymotrypsin deficiency with milder lung disease in patients with cystic fibrosis. Thorax (2001) 0.78
Identification of haptoglobin peptide as a novel serum biomarker for lung squamous cell carcinoma by serum proteome and peptidome profiling. Int J Oncol (2016) 0.77
Mutagenesis of the bovSERPINA3-3 demonstrates the requirement of aspartate-371 for intermolecular interaction and formation of dimers. Protein Sci (2012) 0.76
Three missense variants of metabolic syndrome-related genes are associated with alpha-1 antitrypsin levels. Nat Commun (2015) 0.76
Chronic obstructive pulmonary disease: towards pharmacogenetics. Genome Med (2009) 0.75
Normal development and behaviour of mice lacking the neuronal cell-surface PrP protein. Nature (1992) 9.01
Differentiation of phylogenetically related slowly growing mycobacteria based on 16S-23S rRNA gene internal transcribed spacer sequences. J Clin Microbiol (1998) 4.82
Normal host prion protein necessary for scrapie-induced neurotoxicity. Nature (1996) 4.25
The adolescent outcome of hyperactive children diagnosed by research criteria: I. An 8-year prospective follow-up study. J Am Acad Child Adolesc Psychiatry (1990) 4.02
Novel diagnostic algorithm for identification of mycobacteria using genus-specific amplification of the 16S-23S rRNA gene spacer and restriction endonucleases. J Clin Microbiol (2000) 3.64
Expression of amino-terminally truncated PrP in the mouse leading to ataxia and specific cerebellar lesions. Cell (1998) 3.59
Localization of a short-term memory in Drosophila. Science (2000) 3.58
A vector for expressing foreign genes in the brains and hearts of transgenic mice. Genet Anal (1996) 3.18
A European evidence-based guideline for the prevention of type 2 diabetes. Horm Metab Res (2010) 3.15
Heterogeneous clearance rates of long-lived lymphocytes infected with HIV: intrinsic stability predicts lifelong persistence. Proc Natl Acad Sci U S A (2003) 2.95
The active sites of the eukaryotic 20 S proteasome and their involvement in subunit precursor processing. J Biol Chem (1997) 2.85
Organ distribution of Schmallenberg virus RNA in malformed newborns. Vet Microbiol (2012) 2.83
Fully synthetic human combinatorial antibody libraries (HuCAL) based on modular consensus frameworks and CDRs randomized with trinucleotides. J Mol Biol (2000) 2.73
Determination of language dominance using functional MRI: a comparison with the Wada test. Neurology (1996) 2.71
Is inflammatory bowel disease an independent and disease specific risk factor for thromboembolism? Gut (2004) 2.55
Plant nuclear gene knockout reveals a role in plastid division for the homolog of the bacterial cell division protein FtsZ, an ancestral tubulin. Proc Natl Acad Sci U S A (1998) 2.50
Soluble gp130 is the natural inhibitor of soluble interleukin-6 receptor transsignaling responses. Eur J Biochem (2001) 2.30
Altered circadian activity rhythms and sleep in mice devoid of prion protein. Nature (1996) 2.24
Somatic hypermutation in normal and transformed human B cells. Immunol Rev (1998) 2.22
Clinical evaluation of a Mycobacterium tuberculosis PCR assay. J Clin Microbiol (1995) 2.19
High prion and PrPSc levels but delayed onset of disease in scrapie-inoculated mice heterozygous for a disrupted PrP gene. Mol Med (1994) 2.18
Prion protein devoid of the octapeptide repeat region restores susceptibility to scrapie in PrP knockout mice. Neuron (2000) 2.13
Antioxidant status in patients on chronic hemodialysis therapy: impact of parenteral selenium supplementation. Wien Klin Wochenschr (1997) 2.12
Fibre-years, pulmonary asbestos burden and asbestosis. Int J Hyg Environ Health (2002) 2.03
No propagation of prions in mice devoid of PrP. Cell (1994) 2.02
Take action to prevent diabetes--the IMAGE toolkit for the prevention of type 2 diabetes in Europe. Horm Metab Res (2010) 1.99
Immunodominant CD4+ T-cell epitope within nonstructural protein 3 in acute hepatitis C virus infection. J Virol (1997) 1.98
Cervical cancer screening among Cambodian-American women. Cancer Epidemiol Biomarkers Prev (1999) 1.95
Antioxidant status in patients with acute respiratory distress syndrome. Intensive Care Med (1999) 1.91
Epidemic serogroup B meningococcal disease in Oregon: the evolving epidemiology of the ET-5 strain. JAMA (1999) 1.88
Plasma protein S deficiency in familial thrombotic disease. Blood (1984) 1.82
Ectopic expression of prion protein (PrP) in T lymphocytes or hepatocytes of PrP knockout mice is insufficient to sustain prion replication. Proc Natl Acad Sci U S A (1999) 1.81
Cytokine production by mature and immature CD4-CD8- T cells. Alpha beta-T cell receptor+ CD4-CD8- T cells produce IL-4. J Immunol (1992) 1.80
Cytoskeletal polymer networks: the molecular structure of cross-linkers determines macroscopic properties. Proc Natl Acad Sci U S A (2006) 1.73
Mapping of immunodominant CD4+ T lymphocyte epitopes of hepatitis C virus antigens and their relevance during the course of chronic infection. Hepatology (1995) 1.72
Extended hepatic resection: a 6-year retrospective study of risk factors for perioperative mortality. J Am Coll Surg (2001) 1.69
Prevention of congenital malformations in infants of insulin-dependent diabetic mothers. Diabetes Care (1983) 1.69
Genetic isolation of fragmented populations is exacerbated by drift and selection. J Evol Biol (2007) 1.64
Prenatal diagnosis of alpha-1-antitrypsin deficiency using oligonucleotide probe analysis. Hum Genet (1988) 1.63
Production of infectious duck hepatitis B virus in a human hepatoma cell line. J Virol (1988) 1.62
Evidence for effects of interleukin 4 (B cell stimulatory factor 1) on macrophages: enhancement of antigen presenting ability of bone marrow-derived macrophages. J Immunol (1987) 1.62
Normal host prion protein (PrPC) is required for scrapie spread within the central nervous system. Proc Natl Acad Sci U S A (1996) 1.60
Confirmation of linkage of Friedreich ataxia to chromosome 9 and identification of a new closely linked marker. Genomics (1989) 1.59
Continuous S-(+)-ketamine administration during elective coronary artery bypass graft surgery attenuates pro-inflammatory cytokine response during and after cardiopulmonary bypass. Br J Anaesth (2010) 1.59
Flask-shaped mycoplasmas: properties and pathogenicity for man and animals. Isr J Med Sci (1984) 1.58
The prevalence of poor anticoagulant response to activated protein C (APC resistance) among patients suffering from stroke or venous thrombosis and among healthy subjects. Blood Coagul Fibrinolysis (1994) 1.57
The adolescent outcome of hyperactive children diagnosed by research criteria--III. Mother-child interactions, family conflicts and maternal psychopathology. J Child Psychol Psychiatry (1991) 1.54
Common variants in FCER1A influence total serum IgE levels from cord blood up to six years of life. Allergy (2009) 1.54
Sleep and sleep regulation in normal and prion protein-deficient mice. J Neurosci (1997) 1.53
Mycobacterium heckeshornense sp. nov., A new pathogenic slowly growing Mycobacterium sp. Causing cavitary lung disease in an immunocompetent patient. J Clin Microbiol (2000) 1.52
The European Spine Phantom--a tool for standardization and quality control in spinal bone mineral measurements by DXA and QCT. Eur J Radiol (1995) 1.51
Acute and chronic neuroborreliosis with and without CNS involvement: a clinical, MRI, and HLA study of 27 cases. J Neurol (1991) 1.49
Diagnosis of poststernotomy infection: comparison of three means of assessment. Ann Thorac Surg (1991) 1.48
k-Nearest neighbor models for microarray gene expression analysis and clinical outcome prediction. Pharmacogenomics J (2010) 1.46
Plant species diversity and composition of experimental grasslands affect genetic differentiation of Lolium perenne populations. Mol Ecol (2011) 1.46
The role of complement in inflammation and adaptive immunity. Immunol Rev (2001) 1.45
Biosynthesis of vitamin b2 (riboflavin). Annu Rev Nutr (2000) 1.45
Fuzzy logic control of inspired isoflurane and oxygen concentrations using minimal flow anaesthesia. Br J Anaesth (1996) 1.44
Prognostic impact of an activation of coagulation in lung cancer. Ann Oncol (1997) 1.42
Microheterogeneity of serum glycoproteins and their liver precursors in patients with carbohydrate-deficient glycoprotein syndrome type I: apparent deficiencies in clusterin and serum amyloid P. J Lab Clin Med (1997) 1.42
Fat elimination in acute renal failure: long-chain vs medium-chain triglycerides. Am J Clin Nutr (1992) 1.42
Invasion of human keratinocytes by Staphylococcus aureus and intracellular bacterial persistence represent haemolysin-independent virulence mechanisms that are followed by features of necrotic and apoptotic keratinocyte cell death. Br J Dermatol (2002) 1.42
Evaluation of adults for ADHD. J Am Acad Child Adolesc Psychiatry (1999) 1.40
Long-term effects of in-hospital cardiac rehabilitation on the cardiac risk profile. A case-control study in pairs of siblings with myocardial infarction. Eur Heart J (2001) 1.40
Influence of lupus anticoagulant on a commercially available kit for APC-resistance. Thromb Haemost (1994) 1.39
Routine molecular genotyping of HLA-B27 in spondyloarthropathies overcomes the obstacles of serological typing and reveals an increased B *2702 frequency in ankylosing spondylitis. J Rheumatol (1997) 1.39
Putative association of a TLR9 promoter polymorphism with atopic eczema. Allergy (2007) 1.39
Preliminary results from the third flight of the Millimeter Anisotropy Experiment (MAX). Proc Natl Acad Sci U S A (1993) 1.39
The spastic mouse: aberrant splicing of glycine receptor beta subunit mRNA caused by intronic insertion of L1 element. Neuron (1994) 1.38
[The diagnosis of the osteoporosis risk. New developments and the state of the art 1994]. Dtsch Med Wochenschr (1994) 1.38
The 20210A allele of the prothrombin gene: a risk factor for juvenile stroke? Result of a pilot study. Blood Coagul Fibrinolysis (1998) 1.38
TERT promoter mutations in ocular melanoma distinguish between conjunctival and uveal tumours. Br J Cancer (2013) 1.38
Genetic rescue in interconnected populations of small and large size of the self-incompatible Ranunculus reptans. Heredity (Edinb) (2005) 1.37
Low-dose subcutaneous recombinant interleukin-2 in advanced human malignancy: a phase II outpatient study. Mol Biother (1990) 1.37
Expression and biochemical characterization of human immunodeficiency virus type 1 nef gene product. J Virol (1990) 1.37
Haemophilia B: database of point mutations and short additions and deletions--third edition, 1992. Nucleic Acids Res (1992) 1.36
Homeopathy and conventional medicine: an outcomes study comparing effectiveness in a primary care setting. J Altern Complement Med (2001) 1.34
The prediction of failure of the stem in THR by measurement of early migration using EBRA-FCA. Einzel-Bild-Roentgen-Analyse-femoral component analysis. J Bone Joint Surg Br (1999) 1.33
Glucosamine sulfate in osteoarthritis of the knee. Osteoarthritis Cartilage (1994) 1.33
Hepatitis B knowledge among Vietnamese immigrants: implications for prevention of hepatocellular carcinoma. J Cancer Educ (2000) 1.32
EANM procedure guidelines for radiosynovectomy. Eur J Nucl Med Mol Imaging (2003) 1.31
Identification of DNA gyrase A mutations in ciprofloxacin-resistant isolates of Salmonella typhimurium from men and cattle in Germany. Microb Drug Resist (1995) 1.31
Costs of plasticity in foraging characteristics of the clonal plant Ranunculus reptans. Evolution (2000) 1.30
Hox-C9 activates the intrinsic pathway of apoptosis and is associated with spontaneous regression in neuroblastoma. Cell Death Dis (2013) 1.30
The transcriptional and DNA binding activity of peroxisome proliferator-activated receptor alpha is inhibited by ethanol metabolism. A novel mechanism for the development of ethanol-induced fatty liver. J Biol Chem (2001) 1.30
Identification of a novel thymocyte growth-promoting factor derived from B cell lymphomas. Cell Immunol (1990) 1.30
Haemophilia B: database of point mutations and short additions and deletions--second edition. Nucleic Acids Res (1991) 1.29
Mating structure and inbreeding and outbreeding depression in the rare plant Gentianella germanica (Gentianaceae). Am J Bot (1997) 1.27
Inhibition of human peripheral blood mononuclear cell proliferation by Streptococcus pyogenes cell extract is associated with arginine deiminase activity. Infect Immun (1998) 1.27
Haemophilia A: database of nucleotide substitutions, deletions, insertions and rearrangements of the factor VIII gene. Nucleic Acids Res (1991) 1.26
Glucocerebrosidase mutations in 108 neuropathologically confirmed cases of multiple system atrophy. Neurology (2009) 1.26
The Danish twin register. Acta Genet Med Gemellol (Roma) (1968) 1.25
Active site topology and reaction mechanism of GTP cyclohydrolase I. Proc Natl Acad Sci U S A (1995) 1.24
Zinc plays a key role in human and bacterial GTP cyclohydrolase I. Proc Natl Acad Sci U S A (2000) 1.24
Phenylketonuria: distribution of DNA diagnostic patterns in German families. Hum Genet (1988) 1.24
Isoform specificity in the relationship of actin to dendritic spines. J Neurosci (1997) 1.23
Dapsone in rosacea fulminans. J Eur Acad Dermatol Venereol (2001) 1.22